Keywords: mixed, fortunes, icos, drugs, fail, trials, impotence

Mixed fortunes for ICOS as two drugs fail in trials and impotence drug

Article | 04 November 1999

Print This

ICOS Corp has started pivotal Phase III trials of IC351, a drug in thesame class as Pfizer's blockbuster product Viagra ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in